“We have a long way to go to cure heart disease.” This is the view of Dr. Peter Liu, the recently appointed Scientific Director at the University of Ottawa Heart Institute. Despite the state-of-the-art care available today, doctors are yet to restore a patient’s heart and blood vessels to their
Somewhere between traditional cardiologists and cardiac surgeons sit interventional cardiologists. Like surgeons, interventionists get blood on their gowns in the process of correcting structural problems of the heart, but their approach is more subtle and less invasive. Spending their days in the
Interventional cardiologists at the University of Ottawa Heart Institute are championing broad-based innovation by using catheter-based procedures to treat a variety of conditions. This gallery highlights a minimally invasive procedure, called TAVI (transcatheter aortic valve implantation), for
Heart failure is a disease that challenges the patient and the health care system alike. An often progressive condition with many potential causes and no cure, it can be effectively managed. Doing so is a complex effort that requires diligence and careful monitoring, but a recent study evaluating
Participants at the University of Ottawa Heart Institute’s 25th Annual Research Day attend a research presentation. The program included more than 75 presentations in the categories of basic science, clinical science, and allied and population health. May 7, 2012, marked the 25th Annual Research Day
RAPID GENE, the first-ever bedside genetic test, has received peer-reviewed validation in The Lancet, the world’s leading general medical journal. As first reported in The Beat (Volume 7, Issue 1), RAPID GENE is a point-of-care genetic test that uses a simple cheek swab to assess whether a patient